TrueWealth LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

TrueWealth LLC’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	666
2020 Q1	$1K	Hold	300	–	–	﹤0.01%	676
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	695
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	663
2019 Q2	$2K	Hold	300	–	–	﹤0.01%	647
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	589
2018 Q4	$4K	Hold	300	–	–	﹤0.01%	571
2018 Q3	$7K	Buy	+300	New	+$6.31K	﹤0.01%	541

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

TrueWealth LLC's AMRX Position: Q2 2020 in Review

TrueWealth LLC held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2020 at 300 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #666.

TrueWealth LLC first reported a position in AMRX in Q3 2018 and has held it in 8 quarters since. The position peaked at $7K in Q3 2018. 139 funds tracked by Wall St. Rank hold AMRX as of Q2 2020.

TrueWealth LLC held 300 shares of Amneal Pharmaceuticals worth $1K as of Q2 2020.
TrueWealth LLC left its Amneal Pharmaceuticals share count unchanged in Q2 2020.
Amneal Pharmaceuticals made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #666 holding.
TrueWealth LLC first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 8 quarters since.
TrueWealth LLC's Amneal Pharmaceuticals position peaked at $7K in Q3 2018.
139 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.